Medicare's new ACCESS (Appropriate Care and Coordination for Enhanced Services and Support) payment model fundamentally reshapes how the healthcare system can reimburse AI tools, creating the first governmental reimbursement pathway for autonomous AI agents in patient care.
The model addresses a critical gap. Today, Medicare has no mechanism to pay for AI systems that work between clinical visits. An AI agent monitoring a patient's health status, conducting wellness check-ins, coordinating housing referrals, or ensuring medication adherence performs real clinical value but generates no billable event under existing payment structures. ACCESS solves this by establishing reimbursement codes for longitudinal AI-driven care coordination activities.
This matters because most healthcare AI startups operate in a payment vacuum. They build sophisticated monitoring and coordination tools, then struggle to demonstrate return on investment to hospitals and clinics. Without a clear path to reimbursement, adoption stalls. ACCESS removes that friction by legitimizing AI agent labor as a covered service.
The model works through a capitated payment structure that bundles services. Rather than paying per visit or procedure, Medicare reimburses healthcare systems for managing patient cohorts, including AI-assisted interventions. This aligns incentives around outcomes rather than volume, which rewards effective preventive care and proactive monitoring that AI agents excel at delivering.
The tech industry's relative silence on ACCESS reflects a broader disconnect between healthcare policy and Silicon Valley innovation cycles. Most AI companies focus on direct-to-consumer applications or enterprise software. They miss that regulatory and reimbursement changes quietly unlock entire markets. A payment mechanism that compensates for AI monitoring creates legitimate demand from health systems, insurers, and providers who previously couldn't justify the expense.
Healthcare systems now have financial cover to deploy AI agents for patient monitoring, care coordination, and medication management. This shifts the calculus for hundreds of health tech startups. Rather than building speculative tools hoping for adoption